The Epilepsy Alliance Florida’s 2025 Jacksonville Walk the Talk for Epilepsy drew 245 participants at the Jacksonville Zoo.

New research combining a dog's natural instincts with technology might help people with epilepsy by predicting seizures ...

HealthDay News — For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study published in the May issue of Brain and Behavior.

US biotech GRIN Therapeutics has secured $140 million in Series D funding and signed a licensing deal with Italy's Angelini ...

A proposed new bill would make sure every school in Pennsylvania is ready and prepared to deal with seizures. Senator Lisa ...

NeuroPace reports promising one-year results from its NAUTILUS trial, showcasing the RNS System's effectiveness in treating idiopathic generalized epilepsy with sustained seizure reduction.

US-based NeuroPace has reported the initial primary endpoint one-year outcomes from the two-year NAUTILUS trial of the RNS ...

Raheen's fight would carry over into his adult life, a consistent battle he said slowed him down. Fast forward to Easter 2014, and the doctor's prediction of Raheen eventually developing epilepsy ...

Fintel reports that on May 28, 2025, HC Wainwright & Co. initiated coverage of NeuroPace (NasdaqGM:NPCE) with a Buy ...

I am writing from my mother’s bedroom in Connecticut. Three years ago, my mom fell down the stairs and broke her hip. She had ...

Texans and hemp industry advocates as asking Texas Gov. Greg Abbott to veto, or reject, SB3, a hemp bill that would ban and ...

Analysts have recently evaluated NeuroPace and provided 12-month price targets. The average target is $17.75, accompanied by ...